NYSE: FOLD - Amicus Therapeutics, Inc.

Rentabilidade por seis meses: -19.59%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Amicus Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., биотехнологическая компания, занимается открытием, разработкой и коммерциализацией методов лечения целого ряда редких и орфанных заболеваний. Компания предлагает Галафолд, перорально вводимый фармакологический компаньон с малой молекулой для лечения болезни Фабри. Он также проводит фазу 3 (ATB200-03) клинического исследования AT-GAA для болезни Помпе. Компания имеет соглашения о сотрудничестве и лицензии с Национальной детской больницей и Университетом Пенсильвании. Amicus Therapeutics, Inc. была основана в 2002 году со штаб-квартирой в Крэнбери, штат Нью-Джерси.

Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2007-05-31
ISIN US03152W1099
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://amicusrx.com
Цена ао 8.62
Alteração de preço por dia: 0% (8.62)
Alteração de preço por semana: -6.3% (9.2)
Alteração de preço por mês: -7.71% (9.34)
Alteração de preço em 3 meses: -11.95% (9.79)
Mudança de preço em seis meses: -19.59% (10.72)
Mudança de preço por ano: -24.58% (11.43)
Mudança de preço em 3 anos: +5.38% (8.18)
Mudança de preço em 5 anos: -40.63% (14.52)
Mudança de preço em 10 anos: -31.8% (12.64)
Mudança de preço desde o início do ano: -8.4% (9.41)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 5.42 2
P/BV 14.76 1
P/E 0 0
EV/EBITDA 105.28 1
Total: 2.25

Eficiência

Nome Significado Nota
ROA, % -7.18 0
ROE, % -31.68 0
Total: 1

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA 15.1 0
Total: 3.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 102.49 10
Rentabilidade Ebitda, % -112.63 0
Rentabilidade EPS, % -82.77 0
Total: 2
Mais detalhes

Instituições Volume Compartilhar, %
Vanguard Group Inc 28492486 9.65
Perceptive Advisors LLC 28057456 9.5
Avoro Capital Advisors LLC 27400000 9.28
Blackrock Inc. 22988139 7.78
JP Morgan Chase & Company 17848531 6.04
Wellington Management Group, LLP 15190024 5.14
Redmile Group, LLC 14828321 5.02
Morgan Stanley 13327897 4.51
State Street Corporation 13163085 4.46
William Blair Investment Management, LLC 11647026 3.94

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Virtus LifeSci Biotech Products ETF 1.49718 36.79 0.13953
Global X Guru Index ETF 1.42436 38.91 0.71623
WisdomTree BioRevolution Fund 1.29837 -4.69 0.78691
First Trust Innovation Leaders ETF 1.05119 45.14 0.51521
Direxion Daily S&P Biotech Bull 3x Shares 0.41982 4067.92 0.25924
Future Tech ETF 0.32442 426.34 0.8416
Principal Healthcare Innovators ETF 0.32442 618.5 0.8416
ProShares UltraShort Nasdaq Biotechnology 0.32 -40.36 1.76
Invesco Nasdaq Biotechnology ETF 0.31382 28.58 0.8565
Vanguard Russell 2000 Growth ETF 0.25 23.05 0.60264
iShares Russell 2000 Growth ETF 0.24458 38.04 0.6026
ProShares Ultra Nasdaq Biotechnology 0.21475 51.7 0.85651
Inspire Small/Mid Cap ETF 0.20263 28.65 1.92038
BNY Mellon US Small Cap Core Equity ETF 0.15909 30.07 1.75333
Vanguard Russell 2000 ETF 0.13 17.16 1.48801
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09936 31.36 1.41955
First Trust Long/Short Equity ETF 0.09004 17.29 1.96644
iShares Morningstar Small-Cap Growth ETF 0.08878 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.08878 587.89 0.72598
Schwab U.S. Small-Cap ETF 0.07786 17.47 1.51433
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.07666 21.79 1.42082
ProShares UltraPro Russell2000 0.07157 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.06446 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.06446 391.25 1.60498
iShares Morningstar Small Cap Value ETF 0.0394 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.0394 201.65 2.50476
Fidelity MSCI Health Care Index ETF 0.03675 3 1.46057
ProShares Hedge Replication ETF 0.01955 5.92 1.47892
Humankind US Stock ETF 0.01564 18.81 1.99919
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00992 17.58 1.75869
iShares Russell 3000 ETF 0.00614 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00533 24.86 1.43354
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00406 21.94 1.69572
0.26200.771.3



Supervisor Cargo Pagamento Ano de nascimento
Mr. Bradley L. Campbell M.B.A. CEO, President & Director 984.09k 1976 (49 anos)
Ms. Ellen S. Rosenberg Chief Legal Officer & Corporate Secretary 733.94k 1963 (62 ano)
Ms. Samantha Prout Chief Accounting Officer & Controller N/A 1978 (47 anos)
Andrew Faughnan Senior Director of Investor Relations N/A
Mr. David M. Clark Chief People Officer 701.39k 1976 (49 anos)
Dr. Jill Weimer Ph.D. Chief Science Officer N/A
Mr. Simon Nicolas Reade Harford Chief Financial Officer N/A 1960 (65 anos)
Mr. Patrik S. Florencio Esq. Global Chief Compliance & Risk Officer N/A
Ms. Diana Moore Head of Global Corporate Communications N/A
Dr. Jeffrey P. Castelli Ph.D. Chief Development Officer 1972 (53 ano)

Endereço: United States, Philadelphia, PA , 3675 Market Street - abrir no Google Maps, abrir mapas Yandex
Site: http://amicusrx.com